How to Get Wegovy Covered by Insurance (2026 Guide)

What Does Wegovy Cost Without Insurance?

The list price of Wegovy is approximately $1,349 per month for the maintenance dose (2.4 mg weekly). Over a full year, that adds up to more than $16,000 — a significant financial burden for most households. Novo Nordisk, the manufacturer, does offer a savings card that can bring the cost down to $0 for eligible commercially insured patients and $25/month for others, but those programs have eligibility restrictions and don't apply to Medicare or Medicaid patients.

Generic semaglutide (compounded or branded) has emerged as a lower-cost option, with telehealth providers offering it for $200–$400/month. However, compounded semaglutide availability has shifted as the FDA shortage designation has been updated — more on this below.

Does Insurance Cover Wegovy?

It depends on your plan. As of 2026, coverage varies widely:

• Employer-sponsored plans: Roughly 50–55% of large employer plans now cover at least one GLP-1 weight loss medication, up from about 25% in 2022. However, many still exclude weight loss drugs explicitly in their formulary.
• ACA marketplace plans: Coverage is inconsistent. Some plans now include Wegovy; many do not. You must check your specific formulary.
• Medicare: Medicare Part D now covers Wegovy for patients who have cardiovascular disease (following the SELECT trial results), but still does not cover it purely for obesity without a qualifying comorbidity.
• Medicaid: Coverage varies by state. As of 2026, over 30 states cover GLP-1 medications for obesity under certain conditions.

How to Check Your Coverage

Before calling your insurance company, gather the following information:

• Your insurance card (member ID, group number)
• The drug name: semaglutide injection, brand name Wegovy
• The NDC (National Drug Code) for Wegovy, which your pharmacist can provide

Then follow these steps:

1. Check your formulary online. Log into your insurer's member portal and search for "semaglutide" or "Wegovy" under prescription benefits. Look for the drug tier and any step therapy or prior authorization requirements.
2. Call member services. Ask specifically: "Is Wegovy covered under my plan for weight management? What are the prior authorization criteria?"
3. Ask your pharmacist to run a trial claim. Your pharmacist can submit a test claim to see what your out-of-pocket cost would be before you fill the prescription.

What You Need to Qualify: Prior Authorization Requirements

Most insurance plans that cover Wegovy require prior authorization (PA). To get approved, your physician typically needs to document:

• BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity (e.g., type 2 diabetes, hypertension, sleep apnea, dyslipidemia)
• A history of documented weight loss attempts with diet and exercise
• In some cases, a trial of another weight loss medication (step therapy)
• No contraindications to semaglutide (history of medullary thyroid cancer, pancreatitis, etc.)

This is why having a physician document your medical history accurately is critical. Incomplete documentation is the number one reason prior authorization requests are denied.

How to Appeal a Wegovy Insurance Denial

If your prior authorization is denied, don't give up. Studies show that up to 40% of insurance appeals for specialty medications are ultimately successful. Here's how to fight back:

1. Request the denial reason in writing. Your insurer is legally required to provide a written explanation. The denial letter will specify the exact reason — this tells you exactly what to address in your appeal.
2. Have your doctor write a letter of medical necessity. This letter should directly address the insurer's stated reason for denial and cite your specific clinical situation, lab values, and the medical evidence supporting Wegovy's use (the STEP trials, SELECT cardiovascular trial).
3. Request a peer-to-peer review. Your prescribing physician can request a direct phone call with the insurance company's medical reviewer. This is often the most effective way to overturn a denial.
4. File a formal internal appeal. You typically have 180 days from the denial notice to file. Include all supporting documentation from your doctor.
5. Request an external independent review. If the internal appeal is denied, you have the right to an independent external review in all 50 states. External reviewers overturn insurer decisions in roughly 40–50% of cases for specialty drugs.

Manufacturer Savings Programs and Patient Assistance

Even while you're navigating insurance, you have options to reduce costs:

• Novo Nordisk's NovoCare program: Eligible uninsured or underinsured patients earning up to 400% of the federal poverty level may receive Wegovy free of charge.
• The Wegovy Savings Offer: Commercially insured patients with a valid prescription may pay as little as $0/month for up to 24 months, subject to eligibility and income limits.
• GoodRx and discount cards: These typically do not apply to branded Wegovy at list price, but may help with other semaglutide formulations.

Alternatives If Insurance Won't Cover Wegovy

If insurance coverage remains out of reach, several alternatives are worth considering:

• Ozempic off-label: The 1 mg or 2 mg dose of semaglutide (Ozempic) is FDA-approved for type 2 diabetes and is more commonly covered — some providers prescribe it off-label for weight loss in patients with metabolic risk factors.
• Tirzepatide (Zepbound): Eli Lilly's dual GLP-1/GIP agonist is FDA-approved for obesity and may have different formulary coverage than semaglutide.
• Telehealth providers with compounded semaglutide: Check current FDA guidance on compounded semaglutide availability, which has fluctuated based on shortage status.
• Other GLP-1 medications: Liraglutide (Saxenda) and orlistat have broader insurance coverage in some plans.

The Bottom Line

Getting Wegovy covered by insurance in 2026 is more achievable than it was just a few years ago — but it still requires persistence and proper documentation. Start by verifying your formulary, work closely with your doctor to meet prior authorization criteria, and don't hesitate to appeal a denial. If insurance coverage remains a barrier, there are manufacturer assistance programs and telehealth options that can make treatment more affordable. The most important step is getting started with a physician who understands the insurance landscape and can advocate for your coverage.